Sarah E. Siegelaar

2.2k total citations · 2 hit papers
41 papers, 1.3k citations indexed

About

Sarah E. Siegelaar is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Obstetrics and Gynecology. According to data from OpenAlex, Sarah E. Siegelaar has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Genetics and 7 papers in Obstetrics and Gynecology. Recurrent topics in Sarah E. Siegelaar's work include Diabetes Management and Research (20 papers), Diabetes and associated disorders (13 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (12 papers). Sarah E. Siegelaar is often cited by papers focused on Diabetes Management and Research (20 papers), Diabetes and associated disorders (13 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (12 papers). Sarah E. Siegelaar collaborates with scholars based in Netherlands, United States and Belgium. Sarah E. Siegelaar's co-authors include J. Hans DeVries, J. B. L. Hoekstra, F. Holleman, Jeroen Hermanides, Dirk Jan Stenvers, Robert J. Bosman, Heleen M. Oudemans–van Straaten, Rebecca C. Painter, Scott J. Jacober and Lisa Kerr and has published in prestigious journals such as Endocrine Reviews, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Sarah E. Siegelaar

38 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence

2023 70 citations Dirk Jan Stenvers, Arjan Malekzadeh et al. Frontiers in Endocrinology profile →
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial

2024 55 citations Katrien Benhalima, Dominique Ballaux et al. The Lancet Diabetes & Endocrinology profile →

Peers

Sarah E. Siegelaar

EDM

GENET

SURGE

EPIDE

Christine Maric‐Bilkan United States

Raoul Rooman Belgium

R. Ravi Shankar United States

Alev Eroğlu Altınova Türkiye

I. F. Casson United Kingdom

Ann R. Steenkiste United States

Katherine V. Williams United States

BR Walker United Kingdom

Marietta Stadler United Kingdom

Maddalena Trombetta Italy

Christine Maric‐Bilkan United States

Sarah E. Siegelaar

386 ×0.4

EDM

152 ×0.5

GENET

183 ×0.6

SURGE

157 ×1.0

93 ×0.6

EPIDE

Citations per year, relative to Sarah E. Siegelaar Sarah E. Siegelaar (= 1×) peers Christine Maric‐Bilkan

Countries citing papers authored by Sarah E. Siegelaar

Since Specialization

Citations

This map shows the geographic impact of Sarah E. Siegelaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Siegelaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Siegelaar more than expected).

Fields of papers citing papers by Sarah E. Siegelaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Siegelaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Siegelaar. The network helps show where Sarah E. Siegelaar may publish in the future.

Co-authorship network of co-authors of Sarah E. Siegelaar

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. Siegelaar. A scholar is included among the top collaborators of Sarah E. Siegelaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. Siegelaar. Sarah E. Siegelaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ballaux, Dominique, Gerd Vanhaverbeke, Youri Taes, et al.. (2025). Cost-effectiveness of advanced hybrid closed loop therapy compared to standard insulin therapy for type 1 diabetes in pregnancy: an economic evaluation of the CRISTAL trial. EClinicalMedicine. 81. 103106–103106. 2 indexed citations

Peeters, Marc, Dominique Ballaux, Gerd Vanhaverbeke, et al.. (2025). Who Benefits Most from Advanced Hybrid Closed Loop Therapy in Pregnancy Across Different Subgroups: A Secondary Analysis of the Randomized Controlled CRISTAL Trial. Diabetes Technology & Therapeutics. 28(3). 253–263.

Kalsbeek, Martin J., Felipe Corrêa‐da‐Silva, Andries Kalsbeek, et al.. (2025). Neuropathological changes in the nucleus basalis of Meynert in people with type 1 or type 2 diabetes mellitus. Acta Neuropathologica. 150(1). 35–35.

Kleinendorst, Lotte, Sarah E. Siegelaar, Helen I. Roessler, et al.. (2025). Treatment of overactive KATP channels with glibenclamide in a zebrafish model and a clinical trial in humans with Cantú syndrome. Scientific Reports. 15(1). 17704–17704. 1 indexed citations

Franx, Arie, et al.. (2024). The WHO 2013 oral glucose tolerance test: The utility of isolated glucose measurements - A retrospective cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 296. 371–375. 1 indexed citations

Benhalima, Katrien, Dominique Ballaux, Gerd Vanhaverbeke, et al.. (2024). Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial. The Lancet Diabetes & Endocrinology. 12(6). 390–403. 55 indexed citations breakdown →

Bisschop, Peter H., et al.. (2024). Circadian desynchrony and glucose metabolism. Journal of Pineal Research. 76(4). e12956–e12956. 33 indexed citations

Siegelaar, Sarah E., René Post, Jacquelien J Hillebrand, et al.. (2024). Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery. Pituitary. 27(2). 151–159. 1 indexed citations

McDonald, Timothy J., Richard A. Oram, Pleun de Groen, et al.. (2023). Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes. Diabetes Care. 47(7). 1114–1121. 14 indexed citations

10.

DeVries, J. Hans, Arie Franx, Bas B. van Rijn, et al.. (2023). Fetal and post‐natal outcomes in offspring after intrauterine metformin exposure: A systematic review and meta‐analysis of animal experiments. Diabetic Medicine. 41(2). e15243–e15243. 2 indexed citations

11.

Eekelen, Rik van, Daphne N. Voormolen, Harold W. de Valk, et al.. (2023). Continuous glucose monitoring metrics and pregnancy outcomes in insulin‐treated diabetes: A post‐hoc analysis of the GlucoMOMS trial. Diabetes Obesity and Metabolism. 25(12). 3798–3806. 11 indexed citations

12.

Stenvers, Dirk Jan, et al.. (2023). Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence. Frontiers in Endocrinology. 14. 1215356–1215356. 70 indexed citations breakdown →

13.

Benhalima, Katrien, Sarah E. Siegelaar, Rebecca C. Painter, et al.. (2023). Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets. The Lancet Diabetes & Endocrinology. 11(7). 490–508. 38 indexed citations

14.

Ackermans, Mariëtte T., et al.. (2022). Explaining unexplained hypoglycemia: How LC-MS/MS can help. Practical Laboratory Medicine. 31. e00291–e00291. 1 indexed citations

15.

Hulst, Abraham H., et al.. (2022). Type 1 and other types of diabetes mellitus in the perioperative period. What the anaesthetist should know. Journal of Clinical Anesthesia. 84. 111012–111012. 9 indexed citations

16.

Hulst, Abraham H., Jorinde A. W. Polderman, Sarah E. Siegelaar, et al.. (2020). Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus. British Journal of Anaesthesia. 126(3). 567–571. 37 indexed citations

17.

Siegelaar, Sarah E., J. B. L. Hoekstra, & J. Hans DeVries. (2011). Special considerations for the diabetic patient in the ICU; targets for treatment and risks of hypoglycaemia. Best Practice & Research Clinical Endocrinology & Metabolism. 25(5). 825–834. 11 indexed citations

18.

Siegelaar, Sarah E., et al.. (2011). The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis. Critical Care. 15(5). R205–R205. 54 indexed citations

19.

Siegelaar, Sarah E., Jeroen Hermanides, Heleen M. Oudemans–van Straaten, et al.. (2010). Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Critical Care. 14(6). R224–R224. 52 indexed citations

20.

Siegelaar, Sarah E., Willem Kulik, Henk van Lenthe, et al.. (2009). A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress. Diabetes Obesity and Metabolism. 11(7). 709–714. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact